Related Experiment Video
Updated: Apr 25, 2026

06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.1K
TGFβ: A player on multiple fronts in the tumor microenvironment
1Laboratory of Immunotherapy, Institute of Microbiology v.v.i. , AS CR, Prague , Czech Republic and.
Journal of Immunotoxicology
|August 21, 2014
Summary
Transforming growth factor-beta (TGF-β) signaling impacts cell growth and development. In cancer, TGF-β has a dual role, suppressing early tumors but promoting advanced cancer progression and metastasis.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Transforming growth factor-beta (TGF-β) is crucial for cell signaling, regulating development and growth.
- Altered TGF-β pathway regulation is common in tumors, with TGF-β exhibiting dual roles in tumorigenesis.
- TGF-β can suppress tumor cell growth but promote progression in advanced cancers, leading to poor patient prognosis.
Purpose of the Study:
- To elucidate the multifaceted roles of TGF-β signaling in the tumor microenvironment.
- To understand how TGF-β signaling influences tumor initiation, progression, and metastasis.
- To investigate the impact of TGF-β on anti-tumor immune responses.
Main Methods:
- Review of recent studies on TGF-β signaling in cancer.
- Analysis of TGF-β's effects on cell growth, immune function, and epithelial-to-mesenchymal transition.
- Examination of TGF-β's role in the tumor microenvironment and patient prognosis.
Main Results:
- TGF-β signaling can be tumor-suppressive in early stages but tumor-promoting in advanced cancers.
- TGF-β impairs anti-tumor immunity by inhibiting cytotoxic cells and promoting regulatory T-cells.
- Dysregulated TGF-β signaling induces epithelial-to-mesenchymal transition, driving cancer progression and metastasis.
Conclusions:
- TGF-β signaling is a critical regulator of tumor initiation, progression, and metastasis.
- Targeting TGF-β signaling in the tumor microenvironment may offer therapeutic strategies.
- Understanding TGF-β's complex roles is essential for developing effective cancer treatments.
Related Concept Videos
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment
2.6K
2.6K
TGF - β Signaling Pathway
7.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

